Global Immunohematology Market: Top 4 trends driving the industry size through 2024

The global immunohematology market growth will be driven by growing technological developments in the field of medicine.

The global immunohematology market growth will be driven by growing technological developments in the field of medicine. This growth will be further fueled by the increasing adoption of automated blood screening systems.

The escalating occurrence of hematologic diseases such as thalassemia, leukemia, and sickle-cell-disorders would increase the demand for immunohematology tests. As per an estimation by the Leukemia & Lymphoma Society, out of the 1,806,590 cancer cases diagnosed in the U.S. in 2020, leukemia, myeloma, and lymphoma accounted for nearly 9.9%.

The WHO and other public health organizations worldwide have launched numerous programs and initiatives to provide widespread access to safe and adequate supply of blood and blood components and develop national blood systems. According to a Global Market Insights, Inc., report, global immunohematology market size will surpass US$2.7 billion by 2024. Mentioned below are some key factors driving future industry trends.

Robust demand for gel cards and customized reagents

Gel cards technology segment is poised to grow at a 6.2% CAGR up to 2024 on account of extensive application in cross matching, antigen detection, and alloantibody identification. Gel cards do not require skilled professionals as they are quicker, safer, and less prone to technical/interpretive errors. These benefits make the technology highly preferable in laboratories.

Reagents segment dominated the immunohematology market share with an annual valuation of US$1.2 billion in 2017 and it is expected to gain substantial traction in the coming years. A surge in the number of customized reagents utilized in blood typing and antibody screening processes will bolster the overall industry outlook.

Growing adoption across hospitals and diagnostic labs

Driven by the rising number of accidents and trauma cases requiring emergency services, hospitals captured more than 54.2% revenue share of global immunohematology industry in 2017. The higher adoption rate of consumables and medical products in hospital settings will drive the segment growth.

Reportedly, diagnostic laboratories end-use segment of immunohematology market will expand at significant CAGR through 2024 owing to growing patient preference towards sophisticated diagnostic facilities. Also, an increased number of blood-related diseases will boost the demand for immunohematology products across diagnostic laboratories.

To access sample pages of this report titled, “Immunohematology Market Size By Product (Analyzers, Reagents), By Technology (Biochips, Gel Cards, Microplates, PCR, Erythrocyte-magnetized Technology), By End-Use (Hospitals, Diagnostic Laboratories, Blood Banks) Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 – 2024” in detail along with the table of contents, please click on the link below:

https://www.gminsights.com/request-sample/detail/1652

Prevalence of hematological disorders in Germany and the U.S.

U.S. immunohematology industry size in 2017 was valued at US$616.5 million and it is estimated to show a similar growth trend in the upcoming few years. The regional industry expansion will be driven by the growing incidence of hematological disorders such as thalassemia, leukemia, and sickle cell anemia. Also, the strong presence of well-established players in the region will lead to a competitive industry outlook.

Germany immunohematology market is projected to grow at a 4.8% CAGR up to 2024. The presence of large number of blood banks and trauma centers in the large numbers would fuel the regional industry growth. To ensure the safety and quality of blood and blood components, numerous efforts have been undertaken by regulatory bodies.

Growing preference for automated hematology analyzer

Growing patient inclination towards automated hematology analyzer and serologic techniques such as ABO serum typing will fuel immunohematology industry expansion. Additionally, the growing emphasis of notable industry players towards developing advanced immunohematology techniques shall lead to the introduction of novel therapies.

Leading companies which are part of the global immunohematology industry include Bio-Rad Laboratories, Siemens Healthcare GmbH, Hologic, Ortho Clinical Diagnostics, Grifols, BD (Becton Dickinson), Immucor, MTC Invitro, Abbott, Roche Diagnostics, Antisel, Beckman Coulter, and Thermo Fisher Scientific.

About Global Market Insights, Inc.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Website: https://www.gminsights.com